The aim of the present study was to study a new antiarrhythmic effect of N-deacetyllappaconitine on the general pharmacological irritant effect on the skin, when applied to the conjunctival sac of the eye, mucosal hyperemia and lacrimation, cumulative, allergenic and diuretic effects. At the same time, it does not cause changes, which makes it more secure.
Klyuzhev V.M., Ardashev V.N., Bryuhoveckij A.G. Ishemicheskaya bolezn' serdca. M.: Medicina, 2004. 304 p.
Miller O.N., Bahmet'eva T.A., Guseva I.A., Egorov A.B., Skurihina O.N., Tereshchenko A.V. Prichinno-sledstvennye svyazi vozniknoveniya fibrillyacii predserdij u bol'nyh arterial'noj gipertenziej. Vestnik aritmologii. 2006. № 44. p. 44-48.
Akhiyarov A.A., Lobov A.N., Ivanov S.P., Spirikhin L.V., Gabbasov T.M., Tsyrlina E.M., Yunusov M.S., Valiev N.V., Sadikov A.Z., Sagdullaev S.S. Antiarrhythmic agents based on diterpenoid alkaloid lappaconitine. protonation of n-deacethyllappaconitine in methanol solutions. Russian Chemical Bulletin. 2020. Т. 69. № 3. p. 567-571.
Sanoev, Z.I.,Khamroev, T.T.,Djaxangirov, F.N.,Sadikov, A.Z.,Sagdullaev, S.S. Antiarrhythmic activity of n-deacetyllappaconitine when administered orally. Annals of the Romanian Society for Cell Biology,2021,25(2), pp. 2339–2346
European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes, ETS №123, Strasbourg (1986).
Khabriev R.U. (Ed.). Methodological guide for experimental (preclinical) study of new pharmacological substances. M. 2005. p. 832